We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Controlled Level EVERolimus in Acute Coronary Syndromes (CLEVER-ACS)

This study is currently recruiting participants.
Verified October 2017 by University of Zurich
Sponsor:
ClinicalTrials.gov Identifier:
NCT01529554
First Posted: February 9, 2012
Last Update Posted: October 25, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Swiss National Science Foundation
Novartis
Information provided by (Responsible Party):
University of Zurich
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 31, 2019
  Estimated Primary Completion Date: December 31, 2019 (Final data collection date for primary outcome measure)